4-Isobutoxybenzylamine Acetate - CAS 955997-89-4
Catalog: |
BB060645 |
Product Name: |
4-Isobutoxybenzylamine Acetate |
CAS: |
955997-89-4 |
Synonyms: |
(4-Isobutoxyphenyl)methanamine Acetate |
IUPAC Name: | acetic acid[4-(2-methylpropoxy)phenyl]methanamine |
Description: | 4-Isobutoxybenzylamine Acetate is an intermediate in the synthesis of 1,3-Bis(4-isobutoxybenzyl)urea (B448763), an impurity in the preparation of Pimavanserin (P441800), a drug used in the treatment of Parkinson's disease and psychosis. |
Molecular Weight: | 179.26 + 60.05 |
Molecular Formula: | C11H17NO·C2H4O2 |
Canonical SMILES: | CC(C)COC1=CC=C(C=C1)CN.CC(=O)O |
InChI: | InChI=1S/C11H17NO.C2H4O2/c1-9(2)8-13-11-5-3-10(7-12)4-6-111-2(3)4/h3-6,9H,7-8,12H2,1-2H31H3,(H,3,4) |
InChI Key: | VPEGFBXWSGBVDN-UHFFFAOYSA-N |
Solubility: | DMSO; Methanol |
Appearance: | White Crystals |
References: | Snigdha, S., et al. J. Pharmacol. Exper. Ther., 332, 622 (2010), Meltzer, H., et al. Neuropsychopharmacol., 35, 881 (2010),. |
GHS Hazard Statement: | H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral] |
Precautionary Statement: | P264, P270, P301+P317, P330, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
CN-113292484-A | 3- (4-methylpiperidine-1-yl) -3-benzylurea compound and analogue, preparation method and application thereof | 20210604 |
CN-113274390-A | Application of pimavanserin in preparation of antitumor drugs | 20210604 |
CN-111517966-A | Method for synthesizing p-isobutoxybenzylamine | 20200613 |
CN-113549006-A | Amide derivative and application thereof | 20200426 |
WO-2021218863-A1 | 1,5-dihydro-2,4-benzodiazepine-3-one derivative and application thereof | 20200426 |
CN-111303013-A | Preparation method of pimavanserin | 20200408 |
WO-2021193790-A1 | Aromatic heterocyclic derivative having serotonin receptor binding activity | 20200326 |
WO-2021147818-A1 | 5-ht2a receptor antagonist and application thereof in treating central nervous system diseases | 20200121 |
CN-112521330-A | Novel preparation method of pimavanserin | 20190919 |
CN-110156664-A | A kind of synthetic method of piperazine Ma Selin | 20190529 |
Complexity: | 159 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 2 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 239.15214353 |
Formal Charge: | 0 |
Heavy Atom Count: | 17 |
Hydrogen Bond Acceptor Count: | 4 |
Hydrogen Bond Donor Count: | 2 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 239.15214353 |
Rotatable Bond Count: | 4 |
Topological Polar Surface Area: | 72.6Ų |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Other Building Blocks
Customers Also Viewed
-
[172531-37-2]
Azido-PEG3-acetic acid
-
[132182-92-4]
Pentane, 1,1,1,2,2,3,4,5,5,5-decafluoro-3-methoxy-4-(trifluoromethyl)-
-
[55408-10-1]
Ethyl Tetrazole-5-carboxylate
-
[35153-16-3]
(Z)-10-Tetradecenyl Acetate
-
[104517-96-6]
Ioversol related compound B
-
[3821-81-6]
3-Amino-2-fluoropropionic acid
INDUSTRY LEADERS TRUST OUR PRODUCTS